Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.
about
Multimodality Imaging in CardiooncologyCardiac damage after treatment of childhood cancer: a long-term follow-up.A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemia.Mitral regurgitation after anthracycline treatment for childhood malignancyCardiotoxicity and oncological treatments.Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.Early identification of anthracycline cardiomyopathy: possibilities and implications.Early left ventricular dysfunction in children after hematopoietic stem cell transplantation for acute leukemia: a case control study using speckle tracking echocardiography.Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancyLeft ventricular diastolic function in congenital myotonic dystrophy.NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivorsCardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.Effect of bone marrow transplantation on diastolic function indices.Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography.Clinical Characteristics and Treatment of Cardiomyopathies in Children.Doxorubicin induced heart failure: Phenotype and molecular mechanisms.Anthracycline cardiotoxicity in childhood.Anthracycline-induced cardiotoxicity: prospective cohort study from Pakistan.A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.Role of echocardiography in cancer care.Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.Cardiomyopathy associated with cancer therapy.Survivorship.Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity.Etiological Peculiarities in Pediatric Heart Failure.Body composition of long-term survivors of acute lymphoblastic leukaemia.Daily energy expenditure and physical activity in survivors of childhood malignancy.Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.Myocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy.Myocardial stiffness as assessed by diastolic wall strain in adult survivors of childhood leukaemias with preserved left ventricular ejection fraction.Perception of effort at low and moderate intensity exercise in survivors of childhood acute lymphoblastic leukaemia.
P2860
Q26795452-EDBFE236-8505-4A3F-A9F5-27A8166F33E0Q33336217-9282348F-C16D-46DD-B704-D02C9787784AQ33735167-69B564CE-D73E-449E-AE08-A0B052789060Q33938195-71DD114C-9B8C-42FC-A639-5DBD45BA1B46Q34660647-CF575526-3D20-4F6A-ACFD-C7E2E5D62298Q34746933-489F63ED-B7A7-4325-B8CA-BBBDF9947DD4Q34800157-AA054D6D-D506-44EE-B369-F574AA9AA9C0Q35028620-6EBD4F8F-C7FB-4D14-8B5C-BC40FBC132F5Q35255129-62145B7A-40DA-4EBC-AEA5-AA3CB4C9691EQ35262678-413163E3-8F90-438C-96B4-A58F70DF2A4FQ35557142-0DF923C5-3386-40D4-8CBC-016B45CBC8D2Q36625957-51DBE59D-D748-41C1-B4A7-7C7A19D0010EQ36721024-6D14EC4A-2603-43AB-BE75-66F2A3EBBAB1Q36872695-499811CA-CBD6-4251-B8FB-C7C4F1ED111AQ36886275-FD1D652E-BAC2-4AF6-B8D6-439DDFA36152Q36912561-C47F7EBE-C58D-4B6C-A280-8202E3143E7CQ37165394-FC7EF65E-819A-49EC-9CFF-1461C59DF06BQ37342407-1ABB2DA3-7F77-4644-9895-7A985A5790BDQ37348243-1DDA9D09-D49D-4393-9274-12BC88154A30Q37874172-0B1F7900-65AF-4722-AC44-BEE4D698AB3FQ38112616-9F704086-A039-4A3D-B4E4-229B9D31406BQ38242641-EF4DC19E-4E02-4476-8FC6-927C6B5C29DBQ38306995-DECCF7B6-8382-4B84-90EB-38A5EDDE36CEQ38978044-ED93DFC5-D20F-4ED2-BAA3-1A64E8757E9FQ42022541-42C3A894-AE69-460B-B690-AC638B48763EQ42166988-321D5568-CC96-4D96-B99C-DA61DEFA4B42Q42455091-F23A6F85-B290-4DB0-B948-AC0BE78AFD8CQ43683844-EFC03B66-C56E-44A8-AB36-77935643E819Q44391942-BFB16507-72AD-4496-8C2E-2143C6F17180Q48616033-D0678CEF-4A69-4455-BFA4-2853DC900832Q51777338-1046B35A-3F9E-421F-8ACD-7E1F8FBCA47B
P2860
Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Left ventricular diastolic fun ...... symptoms, and pathophysiology.
@ast
Left ventricular diastolic fun ...... symptoms, and pathophysiology.
@en
type
label
Left ventricular diastolic fun ...... symptoms, and pathophysiology.
@ast
Left ventricular diastolic fun ...... symptoms, and pathophysiology.
@en
prefLabel
Left ventricular diastolic fun ...... symptoms, and pathophysiology.
@ast
Left ventricular diastolic fun ...... symptoms, and pathophysiology.
@en
P2093
P2860
P921
P356
P1476
Left ventricular diastolic fun ...... symptoms, and pathophysiology.
@en
P2093
P2860
P304
P356
10.1136/HRT.73.4.340
P577
1995-04-01T00:00:00Z